Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

66.7%

2 terminated/withdrawn out of 3 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

300%

3 of 1 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01804296Not ApplicableTerminated

rTMS for Depressed Teens: A Sham-Controlled Trial, Part 2

Role: lead

NCT01804270Not ApplicableTerminated

rTMS for Depressed Teens: A Sham-Controlled Trial, Part 1

Role: lead

NCT01502033Not ApplicableCompleted

Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Depressed Teens

Role: lead

All 3 trials loaded